GSK aims to develop vaccine against H1N1 flu virus

GlaxoSmithKline said it will start developing a vaccine against the H1N1 flu virus once it receives a sample of the virus from the World Health Organization. The drugmaker said it is negotiating with Great Britain, France and other European countries about producing 128 million doses of the vaccine, which the company said could take as long as six months to develop.

View Full Article in:

Los Angeles Times (tiered subscription model) · American City Business Journals

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
Actuary
Meridian Health Plan
Detroit, MI
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Director, Payer Marketing
Avalere Health
Washington, DC